1. Home
  2. ANIX vs ITRG Comparison

ANIX vs ITRG Comparison

Compare ANIX & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.31

Market Cap

103.9M

Sector

Health Care

ML Signal

HOLD

Logo Integra Resources Corp.

ITRG

Integra Resources Corp.

HOLD

Current Price

$2.24

Market Cap

486.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
ITRG
Founded
1982
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
103.9M
486.9M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
ANIX
ITRG
Price
$3.31
$2.24
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
★ $9.67
$5.75
AVG Volume (30 Days)
220.4K
★ 1.3M
Earning Date
09-09-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 12.82
N/A
EPS
N/A
★ N/A
Revenue
★ $210,000.00
N/A
Revenue This Year
N/A
$19.41
Revenue Next Year
N/A
$26.85
P/E Ratio
★ N/A
$45.07
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$1.99
52 Week High
$5.46
$4.87

Technical Indicators

Market Signals
Indicator
ANIX
ITRG
Relative Strength Index (RSI) 66.75 36.91
Support Level $3.31 $2.21
Resistance Level $3.48 $2.30
Average True Range (ATR) 0.17 0.11
MACD 0.07 -0.02
Stochastic Oscillator 96.05 22.55

Price Performance

Historical Comparison
ANIX
ITRG

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: